China NMPA Drug Inspection - Tianjin Zhongxin Pharmaceutical Group Co., Ltd. Longshunrong Pharmaceutical - Qingwen Jiedu Tablets
China NMPA drug inspection for Tianjin Zhongxin Pharmaceutical Group Co., Ltd. Longshunrong Pharmaceutical published December 13, 2017. Drug: Qingwen Jiedu Tablets. The Shaanxi Provincial Food and Drug Administration (SPFDA) issued its "2017 Issue 12 Announcement on the Quality of Dru
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Tianjin Zhongxin Pharmaceutical Group Co., Ltd. Longshunrong Pharmaceutical published December 13, 2017. Drug: Qingwen Jiedu Tablets. The Shaanxi Provincial Food and Drug Administration (SPFDA) issued its "2017 Issue 12 Announcement on the Quality of Dru
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox